Hepatitis C virus RNA replication is resistant to tumour necrosis factor-α

References

1. Baeuerle P. A., Baltimore D. 1996; NF- κ B: ten years after. Cell 87:13–20
   [Google Scholar]
2. Bartenschlager R., Lohmann V. 2000; Replication of hepatitis C virus. J Gen Virol 81:1631–1648
   [Google Scholar]
3. Blight K. J., Kolykhalov A. A., Rice C. M. 2000; Efficient initiation of HCV RNA replication in cell culture. Science 290:1972–1974
   [Google Scholar]
4. Bradham C. A., Plumpe J., Manns M. P., Brenner D. A., Trautwein C. 1998; Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 275:387–392
   [Google Scholar]
5. Feduchi E., Alonso M. A., Carrasco L. 1989; Human γ interferon and tumor necrosis factor alpha exert a synergistic blockade on the replication of herpes simplex virus. J Virol 63:1354–1359
   [Google Scholar]
6. Frese M., Pietschmann T., Moradpour D., Haller O., Bartenschlager R. 2001; Interferon- α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82:723–733
   [Google Scholar]
7. Frese M., Schwärzle V., Barth K., Krieger N., Lohmann V., Mihm S., Haller O., Bartenschlager R. 2002; Interferon- γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694–703
   [Google Scholar]
8. Gilles P. N., Fey G., Chisari F. V. 1992; Tumor necrosis factor- α negatively regulates hepatitis-B virus gene expression in transgenic mice. J Virol 66:3955–3960
   [Google Scholar]
9. González-Amaro R., García-Monzón C., García-Buey L. 7 other authors 1994; Induction of tumor necrosis factor- α production by human hepatocytes in chronic viral hepatitis. J Exp Med 179:841–848
   [Google Scholar]
10. Guidotti L. G., Borrow P., Hobbs M. V., Matzke B., Gresser I., Oldstone M. B. A., Chisari F. V. 1996; Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci U S A 93:4589–4594
    [Google Scholar]
11. Guo J.-T., Bichko V. V., Seeger C. 2001; Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75:8516–8523
    [Google Scholar]
12. Höhler T., Krüger A., Gerken G., Schneider P. M., Meyer zum Büschenfelde K. H., Rittner C. 1998; Tumor necrosis factor- α promoter polymorphism at position −238 is associated with chronic active hepatitis C infection. J Med Virol 54:173–177
    [Google Scholar]
13. Hoofnagle J. H. 1997; Hepatitis C: the clinical spectrum of disease. Hepatology 26 (Suppl. 1):15S–20S
    [Google Scholar]
14. Koziel M. J., Dudley D., Afdhal N., Grakoui A., Rice C. M., Choo Q. L., Houghton M., Walker B. D. 1995; HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96:2311–2321
    [Google Scholar]
15. Krieger N., Lohmann V., Bartenschlager R. 2001; Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75:4614–4624
    [Google Scholar]
16. Kroeger K. M., Carville K. S., Abraham L. J. 1997; The −308 tumor necrosis factor α promoter polymorphism affects transcription. Mol Immunol 34:391–399
    [Google Scholar]
17. Liu Z. G., Han J. 2001; Cellular responses to tumor necrosis factor. Curr Issues Mol Biol 3:79–90
    [Google Scholar]
18. Lohmann V., Körner F., Koch J. O., Herian U., Theilmann L., Bartenschlager R. 1999; Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113
    [Google Scholar]
19. Lohmann V., Körner F., Dobierzewska A., Bartenschlager R. 2001; Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75:1437–1449
    [Google Scholar]
20. Löhr H. F., Schlaak J. F., Gerken G., Fleischer B., Dienes H. P., Meyer zum Büschenfelde K. H. 1994; Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161–166
    [Google Scholar]
21. Louis E., Franchimont D., Piron A. 8 other authors 1998; Tumour necrosis factor (TNF) gene polymorphism influences TNF- α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113:401–406
    [Google Scholar]
22. Lucin P., Jonjic S., Messerle M., Polic B., Hengel H., Koszinowski U. H. 1994; Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon- γ and tumor necrosis factor. J Gen Virol 75:101–110
    [Google Scholar]
23. Mayer A., Gelderblom H., Kumel G., Jungwirth C. 1992; Interferon- γ -induced assembly block in the replication cycle of adenovirus 2: augmentation by tumour necrosis factor-α . Virology 187372–376
    [Google Scholar]
24. McClary H., Koch R., Chisari F. V., Guidotti L. G. 2000; Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 74:2255–2264
    [Google Scholar]
25. McGuire W., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. 1994; Variation in the TNF- α promoter region associated with susceptibility to cerebral malaria. Nature 371:508–510
    [Google Scholar]
26. McHutchison J. G. 2002; Hepatitis C advances in antiviral therapy: what is accepted treatment now?. J Gastroenterol Hepatol 17:431–441
    [Google Scholar]
27. McKiernan S., Daly J., Curry M. P., Hegarty J. E., Kelleher D. 1999; Polymorphisms of the TNF- α gene promoter region in hepatitis C infection. Hepatology 30:360
    [Google Scholar]
28. Neumann A. U., Lam N. P., Dahari H., Gretch D. R., Wiley T. E., Layden T. J., Perelson A. S. 1998; Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon- α therapy. Science 282:103–107
    [Google Scholar]
29. Neumann A. U., Lam N. P., Dahari H., Davidian M., Wiley T. E., Mika B. P., Perelson A. S., Layden T. J. 2000; Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J Infect Dis 182:28–35
    [Google Scholar]
30. Paez E., Garcia F., Fernandez C. 1990; Interferon cures cells lytically and persistently infected with African swine fever virus in vitro . Arch Virol 112:115–127
    [Google Scholar]
31. Pasquetto V., Wieland S. F., Uprichard S. L., Tripodi M., Chisari F. V. 2002; Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol 76:5646–5653
    [Google Scholar]
32. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., Bartenschlager R. 2002; Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76:4008–4021
    [Google Scholar]
33. Plaisance S., Vanden Berghe W., Boone E., Fiers W., Haegeman G. 1997; Recombination signal sequence binding protein J κ is constitutively bound to the NF κ B site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol 17:3733–3743
    [Google Scholar]
34. Rosen H. R., McHutchison J. G., Conrad A. J., Lentz J. J., Marousek G., Rose S. L., Zaman A., Taylor K., Chou S. 2002; Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol 97:714–720
    [Google Scholar]
35. Schlüter D., Deckert M. 2002; The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect 2:1285–1292
    [Google Scholar]
36. Theodore D., Fried M. W. 2000; Natural history and disease manifestations of hepatitis C infection. Curr Top Microbiol Immunol 242:44–54
    [Google Scholar]
37. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., Huber C. 1992; Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274
    [Google Scholar]
38. Torre D., Zeroli C., Giola M., Ferrario G., Fiori G. P., Bonetta G., Tambini R. 1994; Serum levels of interleukin-1 α , interleukin-1 β , interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 18:194–198
    [Google Scholar]
39. WHO 2000; Hepatitis C: global prevalence (update). Weekly Epidem Rec 75:18–19
    [Google Scholar]
40. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O., Duff G. W. 1997; Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–3199
    [Google Scholar]
41. Zeuzem S., Herrmann E., Lee J. H., Fricke J., Neumann A. U., Modi M., Colucci G., Roth W. K. 2001; Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α 2a. Gastroenterology 120:1438–1447
    [Google Scholar]